Not applicableStudy completedNCT04941768
What this trial is testing
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Who this might be right for
Carcinoma, Renal Cell
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 105